Back
Keros Therapeutics Stock Predictions
Sponsored
KROS
Sponsored
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.
Buy
68
KROS
Keros Therapeutics
Last Price:
59.58
Seasonality Move:
45.94%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.Keros Therapeutics Stock Forecast
- Over the next 52 weeks, Keros Therapeutics has on average historically risen by 18.9% based on the past 4 years of stock performance.
- Keros Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Keros Therapeutics Stock Undervalued?
The current Keros Therapeutics [KROS] share price is $57.99. The Score for KROS is 68, which is 36% above its historic median score of 50, and infers lower risk than normal. - KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Keros Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Keros Therapeutics has on average historically risen by 18.9% based on the past 4 years of stock performance.
Keros Therapeutics Stock Rating
Buy
68
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics overpriced?
- Keros Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Keros Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com
52-Week Data
52-Week High:
73.00
52-Week Low:
27.02
Prediction Charts
Market Cap:
2.18B
Price in USD:
57.99
Volume:
189.33K
Beta:
1.13
Technical Analysis
SMA50:
53.96
SMA100:
50.66
SMA200:
54.70
52-Wk Change:
103.47%
Stock Predictions
-
Is Keros Therapeutics stock public?
Yes, Keros Therapeutics is a publicly traded company. -
What is the Keros Therapeutics stock quote today?
The Keros Therapeutics stock price is 57.99 USD today. -
How to buy Keros Therapeutics stock online?
You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-3 | 61.09 | 59.90 | 61.09 | 59.40 |
Oct-4 | 60.21 | 60.86 | 61.33 | 59.50 |
Oct-7 | 61.09 | 60.12 | 61.55 | 58.66 |
Oct-8 | 60.00 | 59.66 | 61.00 | 59.56 |
Oct-9 | 59.67 | 57.97 | 59.67 | 57.87 |
Oct-10 | 57.27 | 57.79 | 58.05 | 56.79 |
Oct-11 | 57.65 | 59.78 | 59.88 | 56.95 |
Oct-14 | 59.38 | 60.50 | 61.52 | 58.71 |
Oct-15 | 60.90 | 60.31 | 61.40 | 59.61 |
Oct-16 | 61.21 | 62.18 | 62.52 | 59.60 |
Oct-18 | 61.28 | 61.25 | 61.38 | 59.99 |
Oct-21 | 60.83 | 60.30 | 61.22 | 59.44 |
Oct-22 | 59.79 | 59.33 | 60.56 | 58.99 |
Oct-23 | 59.09 | 57.99 | 60.25 | 57.95 |
Keros Therapeutics Earnings
Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Keros Therapeutics Forecast Revenue Growth
Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.47 per share.
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.